LAEKNA-B (02105) completed the issue of 36 million shares of allocated shares.
Kailai Pharmaceuticals-B (02105) has announced that all conditions for the allotment have been met, and the allotment has been completed on ...
Notice from LAEKNA-B (02105): The conditions for the allotment have all been met, and the allocation was completed on September 17, 2025. According to the terms and conditions of the allotment agreement, 36 million shares have been successfully allocated to no fewer than six underwriters by the exclusive allotment agent at a price of HK$16.30 per share.
Related Articles
UBS: Raises target price of HARBIN ELECTRIC (01133) to 18 Hong Kong dollars, rating "buy"
CMSC: UNITED LAB (03933) is given a "strong recommendation" rating. After the initial success of innovative drugs, the follow-up pipeline is rich.
Gemini's utilization rate jumps to second in the market. TD Cowen raises target price for Alphabet Inc. Class C (GOOGL.US) to $270.
UBS: Raises target price of HARBIN ELECTRIC (01133) to 18 Hong Kong dollars, rating "buy"
CMSC: UNITED LAB (03933) is given a "strong recommendation" rating. After the initial success of innovative drugs, the follow-up pipeline is rich.
Gemini's utilization rate jumps to second in the market. TD Cowen raises target price for Alphabet Inc. Class C (GOOGL.US) to $270.
